((2S,4R)-4-Fluoro-1-methylpyrrolidin-2-yl)methanol, 98%, 10g

2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9,9'-spirobi[fluorene], 98% HPLC,T, 250mg

2-(6-Methoxy-2-naphthyl)propionic acid, 97.0%, 10g

Ethyl 2-chloroethanimidoate hydrochloride, 95.0%, 1g

2,6-Difluoro-4-formylbenzonitrile, 95.0%, 25g

4-Formylbenzenesulfonyl chloride, 96.0%, 250mg

2,6-Dimethylcyclohexanone (mixture of isomers)>98.0%(GC)25mL

Piperazin-1-yl-o-tolyl-methanone hydrochloride, 250mg

Sample vessels Sample tub with screw-cap closure, non-sterile, 200 Piece(s)

2-(3-Chloro-4-(cyclopropylmethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 10g

1-Benzyl 3-methyl pyrrolidine-1,3-dicarboxylate, 95.0%, 1g

N-Ethyl acrylamide, 99.0%, 250mg

Furan-3-yl(phenyl)methanamine hydrochloride, 97%, 250mg